1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased demand for personalized medicine
5.1.1.2. Rising adoption of TDM across various therapeutic fields
5.1.1.3. High importance in patients with solid organ transplantation
5.1.2. Restraints
5.1.2.1. Difficulty in reimbursement policies
5.1.2.2. High capital investments needs
5.1.3. Opportunities
5.1.3.1. Growth in R&D investment by private players
5.1.3.2. Technology developments by manufacturers
5.1.4. Challenges
5.1.4.1. Availability of alternatives procedures
5.2. Cumulative Impact of COVID-19

6. Therapeutic Drug Monitoring Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Data Management Services
6.4. Equipment

7. Therapeutic Drug Monitoring Market, by Technology
7.1. Introduction
7.2. Immunoassays
7.3. Proteomic Technologies

8. Therapeutic Drug Monitoring Market, by Drug Class
8.1. Introduction
8.2. Anti-arrhythmics
8.3. Anti-epileptics
8.4. Antibiotics
8.5. Immunosuppressants

9. Therapeutic Drug Monitoring Market, by End-User
9.1. Introduction
9.2. Hospital Labs
9.3. Private Labs

10. Americas Therapeutic Drug Monitoring Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Therapeutic Drug Monitoring Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Therapeutic Drug Monitoring Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories, Inc.
14.2. Agilent Technologies, Inc.
14.3. Alere, Inc.
14.4. apDia Group
14.5. ARK Diagnostics, Inc.
14.6. Beckman Coulter, Inc.
14.7. Bio-Rad Laboratories, Inc.
14.8. bioMérieux SA
14.9. Buehlmann Laboratories AG
14.10. Cambridge Life Sciences Limited
14.11. Chromsystems Instruments & Chemicals GmbH
14.12. Danaher Corporation
14.13. DiaSystem Scandinavia AB
14.14. Exagen
14.15. F. Hoffmann-La Roche AG
14.16. Grifols, S.A.
14.17. InSource Diagnostics
14.18. Merck KGaA
14.19. Miraca Holdings, Inc
14.20. Myriad Genetics, Inc.
14.21. R-Biopharm AG
14.22. Randox Laboratories Limited
14.23. Sekisui Medical Co., Ltd
14.24. Siemens Healthineers AG
14.25. SQI Diagnostics
14.26. Tecan Trading AG
14.27. Theradiag
14.28. Thermo Fisher Scientific, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2020 VS 2027 (%)
FIGURE 4. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2027
FIGURE 6. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 13. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 15. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2020 VS 2027 (%)
FIGURE 20. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2020 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2027
FIGURE 22. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-ARRHYTHMICS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-ARRHYTHMICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-EPILEPTICS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTICS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 31. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2027
FIGURE 33. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL THERAPEUTIC DRUG MONITORING MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2018-2027 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-ARRHYTHMICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: SCORES
TABLE 49. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: RANKING
TABLE 52. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL THERAPEUTIC DRUG MONITORING MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Alere, Inc.
apDia Group
ARK Diagnostics, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
bioMérieux SA
Buehlmann Laboratories AG
Cambridge Life Sciences Limited
Chromsystems Instruments & Chemicals GmbH
Danaher Corporation
DiaSystem Scandinavia AB
Exagen
F. Hoffmann-La Roche AG
Grifols, S.A.
InSource Diagnostics
Merck KGaA
Miraca Holdings, Inc
Myriad Genetics, Inc.
R-Biopharm AG
Randox Laboratories Limited
Sekisui Medical Co., Ltd
Siemens Healthineers AG
SQI Diagnostics
Tecan Trading AG
Theradiag
Thermo Fisher Scientific, Inc.